Implant Sciences [IMSC] 4Q13 4Q12 FY13 FY12 Sales $2.4M $600,000 $12M $3.4M Net Inc. ($5.5M, 0.10) ($4.4M, 0.12) ($27.4M, 0.56)($14.6M, 0.43) The net loss in the fourth quarter widened on an increase of $1.6 million of stock-based compensation expense, higher operating expenses and increased interest expense on higher borrowings under the company’s credit facility. Expenses were also up on the addition of more sales personnel and related travel as well as a 51% percent increase in research and development to…
Earnings News & Notes
Defense Daily Staff
SHARE:
